Data availability
The data that support the fndings of this study are available from the corresponding author (TX) upon request.
References
Yang L, Du W, Hu T, Liu M, Cai L, Liu Q et al (2022) Survival in breast cancer patients with bone metastasis: A multicenter real-world study on the prognostic impact of intensive postoperative bone scan after initial diagnosis of breast cancer (CSBrS-023). Cancers 14(23):5835
The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271(20):1587–1592
Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V et al (1999) Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 281(17):1586
Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M et al (2020) Bone metastases. Nat Rev Dis Primers 6(1):83
Sohaib SA, Cook G, Allen SD, Hughes M, Eisen T, Gore M (2009) Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol 82(980):632–639
McCartan DP, Prichard RS, MacDermott RJ, Rothwell J, Geraghty J, Evoy D et al (2016) Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging: Bone scan for systemic staging in breast cancer. Br J Surg 103(7):839–844
James J, Teo M, Ramachandran V, Law M, Ip E, Cheng M (2021) Looking for metastasis in early breast cancer: does bone scan help? A retrospective review. Clin Breast Cancer 21(1):e18-21
Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J et al (2015) Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design. Ann Oncol 26(10):2113–2118
Park JW, Jo MK, Lee HM (2009) Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. BJU Int 103(5):615–619
Pouliot F, Beauregard J-M, Saad F, Trudel D, Richard PO, Turcotte É et al (2022) The triple-tracer strategy against metastatic PrOstate cancer (3TMPO) study protocol. BJU Int 130(3):314–322
Funding
Peking University People’s Hospital Scientific Research Development Funds, RDY2021-20, Zixiong Huang.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, Z., Xu, T. Bone metastasis screening strategies in urological malignancies: jades from other hills. World J Urol 41, 1701–1702 (2023). https://doi.org/10.1007/s00345-023-04411-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-023-04411-1